Extensive research on cellencapsulation strategies has enabled the development of a variety oftechnologies capable of immobilizing / enclosing therapeutic entities withinbiocompatible matrices / carriers. Such products offer a myriad of advantages,and have demonstrated the capability to address existing challenges related tocell therapies and certain other types of interventions as well.
To order this 500+ page report, which features 170+ figuresand 395+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030-/249.html
The USD 3.7 billion (by 2030)financial opportunity within the encapsulated cell therapies and encapsulationtechnologies market has been analyzed across the following segments:
§ Type of licensing deal payment
§ Upfront payment
§ Milestone payment
§ Therapeutic area
§ Metabolic disorder
§ Neurological disorder
§ Ophthalmic disorder
§ Oncological disorder
§ Target disease indication
§ Ataxia telangiectasia
§ Breast cancer
§ Diabetes
§ Glaucoma
§ Head and neck cancer
§ Macular telangectasia
§ Pancreatic cancer
§ Parkinson's disease
§ Retinitis pigmentosa
§ Type of encapsulation material used
§ Alginate-based microcapsule
§ Cellulose hydrogel
§ Medical-grade plastic
§ Red blood cell
§ Key geographical region
§ North America
§ Europe
§ Asia-Pacific and rest of the world
The Cell Encapsulation:Focus on Therapeutics and Technologiesv, 2019-2030 reportfeatures the following companies, which we identified to be key players in thisdomain:
§ ALTuCELL
§ Azellon CellTherapeutics
§ Beta-Cell
§ Betalin Therapeutics
§ CellProtectBiotechnology
§ Diatranz Otsuka
§ Encellin
§ EryDel
§ Gloriana Therapeutics
§ Living CellTechnologies
§ MaxiVAX
§ NeurotechPharmaceuticals
§ PharmaCyte Biotech
§ Semma Therapeutics
§ Sernova
Table of Contents
1. Preface
2. ExecutiveSummary
3. Introduction
4. CurrentMarket Landscape
5. EncapsulatedCell Therapies and Encapsulation Technologies for Metabolic Disorders: CompanyProfiles
6. EncapsulatedCell Therapies and Encapsulation Technologies for Non-Metabolic Disorders:Company Profiles
7. PatentAnalysis
8. ClinicalTrial Analysis
9. RecentPartnerships
10. Fundingand Investment Analysis
11. GrantAnalysis
12. PotentialStrategic Partners
13. MarketForecast
14. Conclusion
15. ExecutiveInsights
16. Appendix1: Tabulated Data
17. Appendix2: List of Companies and Organizations
To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
